ABL Diagnostics Launches Applications for Respiratory Viruses such as Influenza, RSV, and SARS-CoV-2

ABL Diagnostics, a Euronext-listed company that develops molecular biology assays and software for microbiology laboratories, has announced today the release of new DeepChek® assays intended to be used for Influenza A, Influenza B, Respiratory Syncytial Virus (RSV) A and Respiratory Syncytial Virus B genotyping. The assays, available in kit format, complete a portfolio of applications dedicated to…

Source